Cite
HARVARD Citation
Sawaki, M. et al. (2022). Adjuvant trastuzumab without chemotherapy for treating early HER2-positive breast cancer in older patients: A propensity score-adjusted analysis of a prospective cohort study. Breast. pp. 245-254. [Online].